548 Afleveringen

  1. A Heart Attack that Led to a Rare Disease Diagnosis

    Gepubliceerd: 30-1-2025
  2. Targeting Rare Liver Diseases with Gene Editing Therapies

    Gepubliceerd: 23-1-2025
  3. Using AI to De-Risk Rare Disease Drug Development

    Gepubliceerd: 16-1-2025
  4. Addressing a Growing Demand for Plasma-Derived Therapies

    Gepubliceerd: 9-1-2025
  5. Empowering Patients with Data to Drive Drug Development

    Gepubliceerd: 2-1-2025
  6. How Advocates Are Advancing a Treatment for an Ultra-Rare Disease

    Gepubliceerd: 26-12-2024
  7. Engineering B Cells to Produce Therapeutic Proteins

    Gepubliceerd: 19-12-2024
  8. A Pipeline Win as BridgeBio Learns to Balance Theory with Practice

    Gepubliceerd: 12-12-2024
  9. Considering What It Will Take for Payers to Embrace Advances in Sequencing

    Gepubliceerd: 5-12-2024
  10. Finding Strength

    Gepubliceerd: 27-11-2024
  11. A Non-Profit Works to Advance a DMD Gene Therapy

    Gepubliceerd: 21-11-2024
  12. Accepting What We Can’t Understand

    Gepubliceerd: 14-11-2024
  13. A Gene Therapy Company Born from a Father’s Efforts to Save his Daughter

    Gepubliceerd: 7-11-2024
  14. Lowering Barriers to Clinical Trial Participation with Do-It-Yourself Blood Sample Collection

    Gepubliceerd: 31-10-2024
  15. Scaling N-of-1 Therapies to Viability

    Gepubliceerd: 24-10-2024
  16. Building Gene Therapies that Address Gain and Loss of Function Simultaneously

    Gepubliceerd: 17-10-2024
  17. How One Woman Climbed from Patient to Advocate

    Gepubliceerd: 10-10-2024
  18. Shortening the Diagnostic Odyssey

    Gepubliceerd: 3-10-2024
  19. Making Exomes More Revealing

    Gepubliceerd: 26-9-2024
  20. How One Patient Organization Catalyzed Drug Development

    Gepubliceerd: 19-9-2024

2 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site